Easywell Biomedicals, Inc.

1799

TW0001799005

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
78.5 ^TWD	+4.67%		+2.61%	+90.07%

05-08	Easywell Biomedicals, Inc. announced a financing transaction	CI
04-07	Easywell Biomedicals, Inc.'s Subsidiary Jiangsu Huahan Pharma-Tech Co., Ltd. Obtains Approval from the Jiangsu Medical Products Administration of China for Compliance with the Good Manufacturing Practice Inspection for Pharmaceuticals	CI

Easywell Biomedical Inc. announced that it has received TWD 200 million in funding

February 19, 2017

On February 20, 2017, Easywell Biomedical Inc. (GTSM:1799) closed the transaction.

Latest news about Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc. announced a financing transaction	05-07	CI
Easywell Biomedicals, Inc.'s Subsidiary Jiangsu Huahan Pharma-Tech Co., Ltd. Obtains Approval from the Jiangsu Medical Products Administration of China for Compliance with the Good Manufacturing Practice Inspection for Pharmaceuticals	04-07	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-29	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-27	CI
Easywell Biomedicals, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	18-11-13	CI

Chart Easywell Biomedicals, Inc.

Duration

Period

More charts

Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EASYWELL BIOMEDICALS, INC.	+90.07%	297M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals

Easywell Biomedicals, Inc.

Equities

1799

TW0001799005

Pharmaceuticals

Easywell Biomedical Inc. announced that it has received TWD 200 million in funding

Latest news about Easywell Biomedicals, Inc.

Chart Easywell Biomedicals, Inc.

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals